JP Patent

JP5154227B2 — Ｎ−（４−フルオロベンジル）−ｎ−（１−メチルピペリジン−４−イル）−ｎ’−（４−（２−メチルプロピルオキシ）フェニルメチル）カルバミドの塩及びその調製

Assigned to アカディア ファーマシューティカルズ インコーポレイテッド · Expires 2013-02-27 · 13y expired

What this patent protects

Patent listed against pimavanserin-tartrate.

Drugs covered by this patent

Patent Metadata

Patent number
JP5154227B2
Jurisdiction
JP
Classification
—
Expires
2013-02-27
Drug substance claim
No
Drug product claim
No
Assignee
アカディア ファーマシューティカルズ インコーポレイテッド
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.